Home > Healthcare > Medical Devices > Diagnostic Devices > ophthalmic handheld devices market
Get a free sample of Ophthalmic Handheld Devices Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Ophthalmic Handheld Devices Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Factors such as the continuous technological advancements, including miniaturization, enhanced imaging capabilities, and integration of smart technologies, growing demand for point-of-care testing, and surging demand for integrated artificial intelligence (AI) in healthcare & machine learning applications collectively contribute to the evolving landscape of the ophthalmic handheld devices industry.
Ophthalmic handheld devices industry from the ophthalmoscopes product type segment reached USD 86.1 million in 2023 owing to increasing prevalence of eye diseases, such as diabetic retinopathy, age-related macular degeneration (AMD), and glaucoma necessitating regular eye examinations.
North America industry size for ophthalmic handheld devices recorded USD 204.5 million in 2023 and is expected to register commendable CAGR from 2024-2032 due to willingness to invest in advanced medical technologies, including ophthalmic handheld devices in the region.
Topcon Corporation, NIDEK CO., LTD., ZEISS International, HEINE Optotechnik GmbH & Co. KG, Halma plc, Quantel Medical, Coburn Technologies Inc., and HAAG-STREIT GROUP are some of the major ophthalmic handheld devices companies worldwide.
Market size for ophthalmic handheld devices was USD 553.6 million in 2023 and is expected to reach over USD 709.2 million by 2032 due to the ongoing technological advancements, the rising incidence of eye disorders, and an expanding geriatric population worldwide.